Design of an international investigator-initiated study on MOdern Treatment of Inhibitor-positiVe pATiEnts with haemophilia A (MOTIVATE)

by Carmen Escuriola Ettingshausen, Robert F. Sidonio
Published 2021-09-01

Emicizumab in tolerized patients with hemophilia A with inhibitors: A single‐institution pediatric cohort assessing inhibitor status

by Glaivy Batsuli, Amanda Greene, Shannon L. Meeks, Robert F. Sidonio Jr
Published 2021-02-01

Elevated von Willebrand factor levels during heavy menstrual bleeding episodes limit the diagnostic utility for von Willebrand disease

by Megan C. Brown, Michael H. White, Rachel Friedberg, Kalinda Woods, Krista Childress, Mona Kulkarni, Robert F. Sidonio Jr
Published 2021-05-01

Optimizing language for effective communication of gene therapy concepts with hemophilia patients: a qualitative study

by Daniel P. Hart, Brian R. Branchford, Sarah Hendry, Robert Ledniczky, Robert F. Sidonio, Claude Négrier, Michelle Kim, Michelle Rice, Matthew Minshall, Claire Arcé, Steve Prince, Maria Kelleher, Sharon Lee
Published 2021-04-01